Zidovudine

Bhana, Nila; Ormrod, Douglas; Perry, Caroline M.; Figgitt, David P.

doi:10.2165/00148581-200204080-00004

Cited by 9 publications

(1 citation statement)

References 57 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is also specified for avoiding vertical transmission of the human immunodeficiency virus (HIV-1) between mother and fetus. Zidovudine indications also include the treatment of adult T-cell leukaemia [25][26][27][28][29][30] . A worldwide spreading viral disease known as a novel severe acute respiratory syndrome called coronavirus 2 (SARS-CoV-2) abbreviated as COVID-19 pandemic (starts spreading in December 2019) which endangered seriously public health and created an urgent need for effective drugs to treat COVID-19 infection 31 .…”

mentioning

confidence: 99%

RETRACTED ARTICLE: Magnetic triazine-based dendrimer as a versatile nanocarrier for efficient antiviral drugs delivery

Ahangarani-Farahani

Bodaghifard

Asadbegi

2022

Sci Rep

View full text Add to dashboard Cite

Nanoscale engineering is an efficient method for the treatment of multiple infectious diseases. Due to the controllable functionalities, surface properties, and internal cavities, dendrimer-based nanoparticles represent high performance in drug delivery, making their application attractive in pharmaceutical and medicinal chemistry. In this study, a dendritic nanostructure (Fe3O4@SiO2@TAD-G3) was designed and fabricated by grafting a triazine-based dendrimer on a magnetic nanomaterial. The structure of synthesized hybrid nanostructure was characterized by Fourier transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD), energy-dispersive X-ray (EDX) spectroscopy, elemental mapping, scanning electron microscopy (SEM), transmission electron microscopy (TEM), thermogravimetric analysis (TGA), and vibrating sample magnetometry (VSM). The prepared nanostructure (Fe3O4@SiO2@TAD-G3) combines the unique properties of magnetic nanoparticles and a hyperbranched dendrimer for biomedical applications. Its dual nature and highly exposed active sites, could make the transportation of drugs to targeted sites of interest through the magnetic field. A study was conducted on model drugs loading (Favipiravir and Zidovudine) and in vitro release behaviour of Fe3O4@SiO2@TAD-G3, which was monitored by ultraviolet spectroscopy. The dendritic nanostructure exhibited high drug-loading capacity for Favipiravir (63.2%) and Zidovudine (76.5%). About (90.8% and 80.2%) and (95.5% and 83.4%) of loaded Favipiravir and Zidovudine were released from Fe3O4@SiO2@TAD-G3 at pH 1.5 and 6.8 respectively, within 600 min and at 37 °C. The initial fast release attributed to the drug molecules on the surface of nanostructure while the drugs incorporated deeply into the pores of the Fe3O4@SiO2@TAD-G3 released with a delay. We proposed that Fe3O4@SiO2@TAD-G3 could be tested as an effective carrier in the targeted (cellular or tissue) delivery of drugs. We think that the prepared nanostructure will not deposit in the liver and lungs due to the small size of the nanoparticles.

show abstract

mentioning

confidence: 99%

RETRACTED ARTICLE: Magnetic triazine-based dendrimer as a versatile nanocarrier for efficient antiviral drugs delivery

Ahangarani-Farahani

Bodaghifard

Asadbegi

2022

Sci Rep

View full text Add to dashboard Cite

show abstract

(Azidothymidine) Zidovudine

2007

Neonatal Formulary

View full text Add to dashboard Cite

Frequency of Hprt mutant lymphocytes and micronucleated erythrocytes in p53‐haplodeficient mice treated perinatally with AZT and AZT in combination with 3TC

Dobrovolsky

Shaddock

Mittelstaedt

et al. 2007

Environ and Mol Mutagen

View full text Add to dashboard Cite

Azidothymidine (AZT) is a nucleoside reverse transcriptase inhibitor (NRTI) that is used for reducing mother-to-child transmission of human immunodeficiency virus I. Combinations of AZT and 3'-thiacytidine (3TC) are even more effective than AZT alone. AZT, however, is a mutagen and carcinogen in rodent models and 3TC can increase the genotoxicity of AZT. Since p53 plays a key role in human and mouse tumorigenesis, p53-haplodeficient mice are currently being evaluated as a model for assessing the carcinogenicity of perinatal exposure to NRTIs. In the present study, male C57BL/6 p53(+/+) and p53(-/-) mice were mated with C3H p53(+/+) females; the pregnant females were treated on gestation day 12 through parturition with 40, 80, and 160 mg/kg of AZT or a combination of 160 mg/kg AZT and 100 mg/kg 3TC (AZT-3TC); the p53(+/+) and p53(+/-) offspring were treated daily after birth through postnatal day (PND) 28. The frequencies of micronucleated reticulocytes (MN-RETs) and micronucleated normochromatic erythrocytes (MN-NCEs) were determined on PND1, PND10, and PND28; the frequency of Hprt mutant lymphocytes was measured on PND28. The frequencies of MN-RETs and MN-NCEs were increased in treated animals at all time points; there were no differences in the responses of p53(+/+) and p53(+/-) animals treated with identical doses of NRTIs. After correction for clonal expansion, both AZT and AZT-3TC treatments induced small but significant increases in the frequency of Hprt mutant lymphocytes in p53(+/-) mice, but not in p53(+/+) mice. The data indicate that p53 haplodeficiency affects the genotoxicity of NRTIs; thus, p53(+/-) mice may be a sensitive model for evaluating the carcinogenicity of perinatal exposure to NRTIs.

show abstract

Zidovudine

Cited by 9 publications

References 57 publications

RETRACTED ARTICLE: Magnetic triazine-based dendrimer as a versatile nanocarrier for efficient antiviral drugs delivery

RETRACTED ARTICLE: Magnetic triazine-based dendrimer as a versatile nanocarrier for efficient antiviral drugs delivery

(Azidothymidine) Zidovudine

Frequency of Hprt mutant lymphocytes and micronucleated erythrocytes in p53‐haplodeficient mice treated perinatally with AZT and AZT in combination with 3TC

Contact Info

Product

Resources

About